Not just in colorectal cancer and lung cancer, CYP24A1 also has been shown to have a pro-survival stimulatory oncogenic effects in breast carcinoma cells as shown by Osani et al. [59] when they suppress the constitutive expression of CYP24A1 and found that tumor growth has been reduced significantly in vivo [59]. This evidence concerns the gene CYP24A1 and lung cancer.